EE689 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment (Monotherapy) for Adult Patients With Non-Small Cell Lung Cancer Following Resection and Platinum-Based Chemotherapy in Greece
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.954
https://www.valueinhealthjournal.com/article/S1098-3015(23)04084-6/fulltext
Title :
EE689 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment (Monotherapy) for Adult Patients With Non-Small Cell Lung Cancer Following Resection and Platinum-Based Chemotherapy in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04084-6&doi=10.1016/j.jval.2023.09.954
First page :
Section Title :
Open access? :
No
Section Order :
10446